Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea.

Jai Min RyuHee Jun ChoiIsaac KimSeok Jin NamSeok Won KimJonghan YuSe Kyung LeeDoo Ho ChoiYeon Hee ParkJong-Won KimJeong-Sun SeoJung-Hoon ParkJeong Eon LeeSung-Won Kimnull null

Published in: Breast cancer research and treatment (2018)

In unselected TNBC patients, we found BRCA 1/2 mutations in 13.1% of overall patients and 14.5% of patients ≤ 60 years. We suggest that Korean women with TNBC diagnosed at ≤ 60 years should be tested for BRCA1/2 mutation.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prostate cancer
risk factors
metabolic syndrome
insulin resistance
patient reported